Cue Health Stock Story

HLTH -  USA Stock  

USD 9.58  0.20  2.04%

The next fiscal quarter end is expected on the 31st of December 2021. The stock goes through an active upward rally. As many retail investors are getting excited about healthcare space, it is fair to concentrate on Cue Health outlook under the current economic conditions. I will address why stockholders ignored this entity since the beginning of the current economic outlook.
Published over a month ago
View all stories for Cue Health | View All Stories
Will Cue Health price rise in December?
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cue Health has an asset utilization ratio of 90.87 percent. This implies that the company is making $0.91 for each dollar of assets. An increasing asset utilization means that Cue Health is more efficient with each dollar of assets it utilizes for everyday operations.
What is the right price you would pay to acquire a share of Cue Health? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated.
Please read more on our stock advisor page.

What is happening with Cue Health this year

Annual and quarterly reports issued by Cue Health are formal financial statements that are published yearly and quarterly and sent to Cue Health stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.
Companies such as Cue Health often view their annual report as an effective marketing tool to disseminate their perspective on company future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.

How does Cue Health utilize its cash?

To perform a cash flow analysis of Cue Health, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Cue Health is receiving and how much cash it distributes out in a given period. The Cue Health cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Cue Health Net Cash Flow from Operations is most likely to increase significantly in the upcoming years. The last year's value of Net Cash Flow from Operations was reported at 106.55 Million

Payment of 17452 shares by Gallagher John E of Cue Health subject to Rule 16b-3

Legal trades by Cue Health insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Cue Health insider trading alert for payment of common stock by Gallagher John E, Chief Financial Officer, on 30th of December 2021. This event was filed by Cue Health Inc with SEC on 2021-12-30. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Is Cue Health a risky opportunity?

Let's check the volatility. Cue Health is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Cue Health (NASDAQ:HLTH) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. locking in a share of a Cue Health stock makes you a part-owner of that company.

Cue Health Current Consensus

Here is the current trade recommendation based on an ongoing consensus estimate among financial analysis covering Cue Health. The Cue Health consensus assessment is calculated by taking the average estimates from all of the analysts covering Cue Health

Strong Buy
Strong Buy266.67
Strong Sell00.0

Our perspective of the current Cue Health rise

The kurtosis is down to -0.54 as of today.
As of the 27th of November, Cue Health shows the risk adjusted performance of (0.12), and Mean Deviation of 5.83. Cue Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Cue Health, which can be compared to its rivals. Please confirm Cue Health variance, as well as the relationship between the value at risk and skewness to decide if Cue Health is priced correctly, providing market reflects its regular price of 11.45 per share. Given that Cue Health has jensen alpha of (1.35), we suggest you to validate Cue Health's prevailing market performance to make sure the company can sustain itself at a future point.

Our Bottom Line On Cue Health

While many other companies within the health information services industry are still a little expensive, even after the recent corrections, Cue Health may offer a potential longer-term growth to stockholders. To summarize, as of the 27th of November 2021, we believe that at this point, Cue Health is undervalued with low probability of financial unrest within the next 2 years. Our primary Buy-Hold-Sell recommendation on the company is Hold.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Cue Health. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to